Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome.
Saved in:
| Title: | Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome. |
|---|---|
| Authors: | Kidd DP; Department of Clinical Neurosciences, Royal Free Hospital, Pond Street, London, NW3 2QG, UK. d.kidd@ucl.ac.uk.; Behçet's Syndrome Centre of Excellence, Dental Institute, Royal London Hospital, Whitechapel, London, E1 1BB, UK. d.kidd@ucl.ac.uk. |
| Source: | Journal of neurology [J Neurol] 2015 Dec; Vol. 262 (12), pp. 2676-7. Date of Electronic Publication: 2015 Sep 26. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26410745 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kidd+DP%22">Kidd DP</searchLink>; Department of Clinical Neurosciences, Royal Free Hospital, Pond Street, London, NW3 2QG, UK. d.kidd@ucl.ac.uk.; Behçet's Syndrome Centre of Excellence, Dental Institute, Royal London Hospital, Whitechapel, London, E1 1BB, UK. d.kidd@ucl.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220423161%22">Journal of neurology</searchLink> [J Neurol] 2015 Dec; Vol. 262 (12), pp. 2676-7. <i>Date of Electronic Publication: </i>2015 Sep 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>0423161 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1459 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203405354%22">03405354 </searchLink><i>NLM ISO Abbreviation: </i>J Neurol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26410745 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00415-015-7897-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2676 Titles: – TitleFull: Rituximab is effective in severe treatment-resistant neurological Behçet's syndrome. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kidd DP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2015 Dec Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1432-1459 Numbering: – Type: volume Value: 262 – Type: issue Value: 12 Titles: – TitleFull: Journal of neurology Type: main |
| ResultId | 1 |